Manifestations of Liver Impairment and the Effects of MH-76, a Non-Quinazoline α1-Adrenoceptor Antagonist, and Prazosin on Liver Tissue in Fructose-Induced Metabolic Syndrome

Manifestations of Liver Impairment and the Effects of MH-76, a Non-Quinazoline α1-Adrenoceptor Antagonist, and Prazosin on Liver Tissue in Fructose-Induced Metabolic Syndrome

Excessive fructose consumption may lead to metabolic syndrome, metabolic dysfunction-associated fatty liver disease (MAFLD) and hypertension. α1-adrenoceptors antagonists are antihypertensive agents that exert mild beneficial effects on the metabolic profile in hypertensive patients. However, they a...

Full description

Bibliographic Details
Main Authors: Monika Kubacka, Barbara Nowak, Monika Zadrożna, Małgorzata Szafarz, Gniewomir Latacz, Henryk Marona, Jacek Sapa, Szczepan Mogilski, Marek Bednarski, Magdalena Kotańska
Format: Article
Language:English
Published: MDPI AG 2023-11-01
Series:Metabolites
Subjects:
metabolic dysfunction-associated fatty liver disease
hypertension
α1-adrenoceptor antagonist
fructose
metabolic syndrome
Online Access:https://www.mdpi.com/2218-1989/13/11/1130

Internet

https://www.mdpi.com/2218-1989/13/11/1130

Similar Items